Will Trump adopt Biden's Medicare/Medicaid expansion proposal by Jan 20, 2025? | Binary | | | 22 days ago | |
Will President-elect Trump endorse Medicare and Medicaid coverage for anti-obesity medications by March 2025? | Binary | | | 27 days ago | |
Bernie Sanders introduces bill targeting drug price reductions by Dec 31, 2024? | Categorical | | | 6 months ago | |
Wegovy or Ozempic prices reduced in the U.S. by June 30, 2024? | Binary | | | 6 months ago | |
Novo Nordisk facility construction completed by Dec 31, 2024? | Binary | | | 6 months ago | |
Novo Nordisk creates 1,000 jobs at new facility by Dec 31, 2024? | Binary | | | 6 months ago | |
Number of new facilities announced by Novo Nordisk in the U.S. by Dec 31, 2024? | Categorical | | | 6 months ago | |
Novo Nordisk U.S. market share for weight-loss treatments by Dec 31, 2024? | Categorical | | | 6 months ago | |
Outcome of the U.S. Senate HELP Committee's vote on June 18 | Categorical | | | 6 months ago | |
Public reaction to U.S. Senate HELP Committee's actions by December 31, 2024 | Categorical | | | 6 months ago | |
Novo Nordisk's response to U.S. Senate HELP Committee by September 30, 2024 | Categorical | | | 6 months ago | |
Will Doug Langa appear before the U.S. Senate HELP Committee by August 31, 2024? | Binary | | | 6 months ago | |
Will Novo Nordisk reduce the prices of Ozempic and Wegovy in the U.S. by December 31, 2024? | Binary | | | 6 months ago | |
Ozempic Global Sales in 2024 | Categorical | | | 7 months ago | |
Ozempic Top-Prescribed Drug for Type 2 Diabetes by 2024 | Binary | | | 7 months ago | |
Ozempic Expanded FDA Approval by 2024 | Binary | | | 7 months ago | |
Global Approval of Ozempic for Kidney Disease by 2024 | Categorical | | | 7 months ago | |
Competitor Drug Outperforms Ozempic by Mid-2025 | Binary | | | 7 months ago | |
Novo Nordisk Market Share in Diabetes Treatment by End of 2024 | Categorical | | | 7 months ago | |
Significant increase in Ozempic sales next quarter? | Binary | | | 7 months ago | |
Ozempic approved for chronic kidney disease treatment by end of 2024? | Binary | | | 7 months ago | |
Global adoption of Ozempic as standard treatment by end of 2024 | Categorical | | | 7 months ago | |
Competitor similar drug announcements by end of 2024? | Binary | | | 7 months ago | |
What will be the outcome of the next major clinical trial involving semaglutide by mid-2025? | Categorical | | | 7 months ago | |
Which global region will show the highest adoption rate of Ozempic by end of 2024? | Categorical | | | 7 months ago | |
Will a competing drug show better or comparable results to Ozempic by end of 2024? | Binary | | | 7 months ago | |
Will FDA approve a higher dosage of Ozempic for expanded treatment by end of 2024? | Binary | | | 7 months ago | |
Novo Nordisk announces production cut due to fire? | Binary | | | 7 months ago | |
Competitors introduce similar products by October 2024? | Binary | | | 7 months ago | |
Competitor reactions to 'Vital Pursuit' by end of 2024 | Categorical | | | 7 months ago | |
Top-selling 'Vital Pursuit' product in Q4 2023 | Categorical | | | 7 months ago | |
Market share ranking of Hims & Hers weight loss program by end of 2024 | Categorical | | | 7 months ago | |
Hims & Hers stock stays above surge level by end of 2024? | Binary | | | 7 months ago | |
FDA action against Hims & Hers GLP-1 injections by end of 2024? | Binary | | | 7 months ago | |
Sales growth of Hims & Hers GLP-1 injections by end of 2024 | Categorical | | | 7 months ago | |
Customer satisfaction ratings for Hims & Hers GLP-1 injections by end of 2024 | Categorical | | | 7 months ago | |
FDA Approval for Hims & Hers Health GLP-1 injections by mid-2025? | Binary | | | 7 months ago | |
Annual revenue growth of Hims & Hers Health post GLP-1 launch | Categorical | | | 7 months ago | |
Market share of Hims & Hers Health in telehealth weight-loss by end of 2024 | Categorical | | | 7 months ago | |
Competitors launch similar weight loss injections by end of 2024? | Binary | | | 7 months ago | |
HIMS stock price increase by end of 2024 | Categorical | | | 7 months ago | |
HIMS stock maintains 30% increase by end of Q3 2024? | Binary | | | 7 months ago | |
HIMS GLP-1 injection sales hit target within 6 months? | Binary | | | 7 months ago | |
Will Kelly Clarkson launch a health and wellness program by end of 2024? | Binary | | | 7 months ago | |
Which medication did Kelly Clarkson use for weight loss? | Categorical | | | 7 months ago | |
Increase in sales of Clarkson's weight loss medication within six months? | Binary | | | 7 months ago | |
Will Kelly Clarkson endorse her weight loss medication by end of 2024? | Binary | | | 7 months ago | |
Kelly Clarkson's weight status by end of 2024 | Categorical | | | 7 months ago | |
New Social Media Policies for Celebrity Comments in 2024? | Binary | | | 8 months ago | |
Streisand Issues Another Apology in 2024? | Binary | | | 8 months ago | |
Public Reaction to Streisand's Apology | Categorical | | | 8 months ago | |
Will EMA approve semaglutide for obstructive sleep apnea by end of 2025? | Binary | | | 8 days ago | |
Will FDA approve semaglutide for Alzheimer's treatment by end of 2025? | Binary | | | 8 days ago | |
Most prescribed diabetes drug in Europe by end of 2025? | Categorical | | | 9 days ago | |
Will Novo Nordisk announce a new Alzheimer's drug based on semaglutide by end of 2024? | Binary | | | 2 months ago | |
CDC reports decline in overdose deaths for 2024 by March 2025? | Binary | | | 2 months ago | |
Insurance covers GLP-1 agonists for substance use disorder by October 2025? | Binary | | | 2 months ago | |
Will the U.S. Senate pass new legislation to regulate drug prices by end of 2024? | Binary | | | 3 months ago | |
Will the FDA approve Wegovy for reducing heart failure risk by 29% by Dec 31, 2024? | Binary | | | 4 months ago | |
Will Myricx Pharma start Phase 1 clinical trials for NMTi-ADC therapeutics by end of 2024? | Binary | | | 6 months ago | |
Percentage increase in apparel retail sales attributed to Ozempic users by end of 2024 | Categorical | | | 6 months ago | |
New fashion trend for 'edgier' clothes by end of 2024? | Binary | | | 6 months ago | |
Lafayette 148 reports sales boost in smaller-sized clothing by end of Q3 2024? | Binary | | | 6 months ago | |
Novo Nordisk stock price changes by end of 2024 | Categorical | | | 7 months ago | |
Ozempic market share changes by end of 2024 | Categorical | | | 7 months ago | |
How will Novo Nordisk's stock price change by the end of 2024 following the FLOW trial results? | Categorical | | | 7 months ago | |
Will Ozempic significantly increase its market share in its treatment categories by end of Q3 2024? | Binary | | | 7 months ago | |
Novo Nordisk stock drops over 10% post-fire? | Binary | | | 7 months ago | |
Nestlé expands 'Vital Pursuit' product line by October 2024? | Binary | | | 7 months ago | |
Market share of 'Vital Pursuit' by October 2024 | Categorical | | | 7 months ago | |
Nestlé's 'Vital Pursuit' hits $50 million in sales by April 2024? | Binary | | | 7 months ago | |
Consumer satisfaction for 'Vital Pursuit' by October 2024 | Categorical | | | 7 months ago | |
Stock price increase due to 'Vital Pursuit' by October 2024 | Categorical | | | 7 months ago | |
'Vital Pursuit' line hits sales target in Q1 2024? | Binary | | | 7 months ago | |
New supplements added to 'Vital Pursuit' by mid-2024? | Binary | | | 7 months ago | |
'Vital Pursuit' available internationally by end of 2024? | Binary | | | 7 months ago | |
Hims & Hers expands weight loss program by mid-2025? | Binary | | | 7 months ago | |
Competitor price reduction in response to Hims & Hers Health by end of 2024? | Binary | | | 7 months ago | |
HIMS market share in weight loss sector by mid-2025 | Categorical | | | 7 months ago | |
Public perception of Kelly Clarkson's weight loss method in next six months | Categorical | | | 7 months ago | |
Celebrity Involvement in Health Inquiry Discussions | Categorical | | | 8 months ago | |
Will Novo Nordisk complete Odense facility construction by end of 2027? | Binary | | | 7 days ago | |
Will Novo Nordisk's Odense facility create 400 permanent jobs by end of 2028? | Binary | | | 7 days ago | |
Novo Nordisk boosts Wegovy and Ozempic production by 30% by mid-2025? | Binary | | | 7 days ago | |
Will WHO include semaglutide in essential medicines list by end of 2025? | Binary | | | 8 days ago | |
What will be Novo Nordisk's market share in anti-obesity drugs by 2025 end? | Categorical | | | 9 days ago | |
What will be Novo Nordisk's revenue growth rate for 2025? | Categorical | | | 9 days ago | |
Will Novo Nordisk boost Wegovy and Ozempic production by 20% by mid-2025? | Binary | | | 9 days ago | |
Hims & Hers Health, Inc. stock recovers to pre-announcement level by Q1 2025? | Binary | | | 12 days ago | |
Will Congress approve Medicare/Medicaid expansion for obesity drugs by end of 2024? | Binary | | | 22 days ago | |
Will Medicare and Medicaid cover anti-obesity drugs like Wegovy by end of 2025? | Binary | | | 26 days ago | |
Will Congress pass a bipartisan bill for obesity drug coverage by end of 2024? | Binary | | | 26 days ago | |
Will Novo Nordisk and Eli Lilly shares rise over 10% by June 2025? | Binary | | | 26 days ago | |
Which obesity drug will see largest Medicare/Medicaid prescription increase by 2025? | Categorical | | | 26 days ago | |
Which company will see the highest sales increase from Medicare and Medicaid anti-obesity drug coverage by end of 2025? | Categorical | | | 27 days ago | |
Will Medicare and Medicaid beneficiaries receive anti-obesity medication coverage by June 2025? | Binary | | | 27 days ago | |
Will Eli Lilly or Novo Nordisk report increased sales of weight-loss drugs by mid-2025? | Binary | | | 27 days ago | |
Will Congress approve Medicare and Medicaid coverage for weight-loss drugs by end of 2024? | Binary | | | 27 days ago | |
Will the CBO revise the $35 billion estimate for Medicare weight-loss drug coverage by end of 2025? | Binary | | | 27 days ago | |
Will Medicaid cover weight-loss drugs for 4 million adults by June 2025? | Binary | | | 27 days ago | |
